Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 Q2- Text added to 2013 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adjudicated, Adjudication, advocacy, asterisk, attributable, began, cancer, case, cGMP, chosen, CKD, clock, concurrent, counsel, decision, demonstrate, digit, disqualification, distracting, DSMB, enroll, enrolling, enrollment, entitled, external, frequently, function, futility, GCP, halt, hepatic, immunogenicity, immunotherapy, imposition, inconclusive, interpretation, IRB, larger, LOI, lost, marked, motion, multicenter, nanoparticle, necessitate, noninferiority, occupy, overseen, peak, promising, prone, proximity, randomized, reflect, repeat, repeated, resetting, seroprotection, shipment, side, site, SPR, stability, stayed, stipulation, stratified, subset, Suitability, summer, susceptible, TechnologiesCorporation, theSEC, toDynavax, unacceptable, Underwriting, unexpected, unforeseen, unknown, unoccupied, unwarranted, withthe
Removed:
adult, Dr, expansion, immunoregulatory, immunostimulatory, inhibitor, investigational, nomination
Valuein 2013 Q2 filing- Value in 2013 Q3 filing
Original filings
Filing view